Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes. It is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.Reference standards of Ozagrel API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ozagrel Sodium (JP 0171)
Catalogue No.:PA JP0171
CAS :
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
